Cara Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Cara Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 50% to $20,968,000. Profit margin reached -565%. Total operating expenses were $136,289,000.
Profit Margin
| 2014 | 3.17M | -17.74M | -558.55% |
|---|---|---|---|
| 2015 | 3.80M | -24.69M | -649.22% |
| 2016 | 86K | -57.28M | -66604.65% |
| 2017 | 911K | -58.12M | -6380.35% |
| 2018 | 13.46M | -74.01M | -549.51% |
| 2019 | 19.88M | -106.37M | -534.91% |
| 2020 | 135.08M | 8.41M | 6.23% |
| 2021 | 23.02M | -88.19M | -382.98% |
| 2022 | 41.86M | -83.41M | -199.23% |
| 2023 | 20.96M | -118.51M | -565.21% |
0HTC.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 20.96M | 41.86M | 23.02M | 135.08M | 19.88M | 13.46M | 911K | 86K | 3.80M | 3.17M |
Cost of revenue | 6.17M | 7.26M | 1.55M | 107.07M | 113.16M | 0 | 48.52M | 0 | 21.22M | 15.06M |
Gross profit | 14.79M | 34.60M | 21.47M | 28.01M | -93.27M | 13.46M | -47.61M | 86K | -17.41M | -11.89M |
Operating exp. | ||||||||||
Research and development | 108.51M | 91.87M | 82.70M | 107.85M | 113.82M | 75.53M | 48.52M | 49.25M | 21.22M | 15.06M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 136.28M | 122.13M | 112.11M | 129.69M | 131.56M | 90.85M | 60.39M | 58.48M | 28.99M | 21.24M |
Operating income | -121.49M | -87.53M | -89.08M | 5.38M | -111.67M | -77.38M | -59.48M | -58.4M | -25.18M | -18.07M |
Other income (expenses), net | 2.98M | 2.06M | 642K | 2.33M | 4.49M | 2.98M | 1.15M | 652K | 101K | 126K |
Income before tax | -118.51M | -85.47M | -88.44M | 7.71M | -107.18M | -74.40M | -58.32M | -57.74M | -25.08M | -17.94M |
Income tax expense | 0 | -2.06M | -248K | -691K | -816K | -389K | -204K | -468K | -397K | -201K |
Net income | -118.51M | -83.41M | -88.19M | 8.41M | -106.37M | -74.01M | -58.12M | -57.28M | -24.69M | -17.74M |
Earnings per share | ||||||||||
Basic EPS | -2.19 | -1.55 | -1.74 | 0.18 | -2.49 | -2.06 | -1.86 | -2.1 | -1 | -0.85 |
Diluted EPS | -2.19 | -1.55 | -1.74 | 0.18 | -2.49 | -2.06 | -1.86 | -2.1 | -1 | -0.85 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |